CClinicalTrials.gg
CompletedNCT04129814Updated Oct 21, 2019

The Effects of Non -Surgical Periodontal Treatment on The Severity of Erectile Dysfunction

An interventional study of Non surgical periodontal therapy in Periodontitis and Erectile Dysfunction, sponsored by Taibah University. Completed. Open to male participants aged 30 Years to 40 Years. Per ClinicalTrials.gov, last updated 2019-10-21.

Sponsored by Taibah University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 6 months after the study started (first participant enrolled Apr 2016, registered Oct 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
30 Years to 40 Years
Sex
Male
01

Study summary

The aim of the present study is to study the influence of periodontal therapy (non-surgical) on the severity of erectile dysfunction(ED) among patients with chronic periodontitis and moderate or severe ED.

Read the detailed description

there no sufficient data to determine a possible link between erectile dysfunction ( ED) and periodontitis. Therefore, the purpose of this clinical trial is to study the influence of periodontal therapy (non-surgical) on the severity of ED among patients with chronic periodontitis and moderate or severe ED.

Sample size: The total number of patients in the current trial will be 140 to requite dropout rate during follow-up period.

Patients and study design:

The current trial is a single-blinded, randomized, parallel, controlled clinical study.

The patients with severe or moderate ED will selected from attendants of Andrology Outpatients Clinic, Tanta University Hospital and will referred to Periodontology Department, Tanta University. Statistical software (STATA 13.1, Stata Corp, Texas, USA) will be used on study participants for random allocation that identify to which group the patients will enrolled, using 1:1 allocation ratio.

Intervention protocol The patients will included in this study if they met the inclusion criteria. The IIEF is an appropriate questionnaire that is used for assessment of men sexual function, especially the ED. . Subjects with scores > 25 will assessed as men with normal sexual function while those with scores ≤ 25 will diagnosed as patients with ED. Following this, participants will directed to periodontology department to assess their periodontal health . After periodontal screening, all eligible patients will informed of potential risks, study objective, and benefits of their participation in this study. Non-surgical periodontal treatment that will be performed by the same periodontist for all participants within a test group at baseline and after three months for patients in a control group. Therefore, no periodontal treatment will be performed during the follow-up period in control group. D

Clinical and periodontal evaluation Thorough medical history, data on age, gender and socio-demographic characteristics will be gathered for all participants in studied groups at baseline. A full-mouth periodontal screening will be carried out by one specialist using a manual probe (Hu-Friedy, Chicago, IL, USA). Prior the current study, test-retest exercises will be performed in 20 patients to assess intra-examiner calibration. The periodontal parameters will be assessed at baseline and at 3 months that consist of PD, CAL, visible dental plaque (will be assessed at 4 sites per each tooth using a probe and will be recorded as present or absent) and bleeding on probing (BOP) (will be recorded as ratio of sites displaying bleeding after light probing) 10. After exclusion of third molars; for each tooth BOP, CAL and PD will be monitored at 6 sites. The IIEF scores will be recorded at baseline and 3 months for both groups.

Cytokine collection and evaluation:

Quantitative assessment of TNF-α in saliva and serum will be done by commercially available kit (Ray Bio Human TNF-α Enzyme Immunoassay).

02

Conditions studied

  • Periodontitis
  • Erectile Dysfunction

Keywords

  • Chronic periodontitis
  • Prognosis
  • Erectile Dysfunction
03

In context

Periodontitis

1,635 studies on the registry are indexed under Periodontitis; 327 are open to participants now.

This study's enrollment of 140 is above the median of 45 across 1,191 interventional studies indexed under Periodontitis.

Browse Periodontitis studies →

Lead sponsor

Taibah University is the lead sponsor of 18 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 40 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  • Age from 30 to 40 years
  • Diagnosis with chronic periodontitis using the classification system of (Armitage, 1999)19 for periodontal diseases
  • Presence of at least sixth permanent teeth excluding the third molars20
  • Clinical attachment level (CAL) and pocket depth (PD) ≥4 mm in more than 30% of sites19
  • Severe or moderate ED
  • Male patients
  • Married

Exclusion criteria

Exclusion Criteria:

  • Alcoholism and smokers
  • Presence of any systemic disorders that may affect ED or periodontal health such as heart disease, diabetes mellitus, and hypertension18
  • Antimicrobial therapies in the last 6 months
  • Periodontal treatment in the last 6 months
  • Drug therapy that may cause ED as side effects such as atenolol and hydrochlorothiazide
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
140 participants (actual)

Study arms

  • Experimental
    test group

    Non-surgical periodontal treatment consisted of oral hygiene instructions (OHI), single session full-mouth scaling and root planing (SRP)

    Procedure: Non surgical periodontal therapy

  • No intervention
    control group

    no periodontal treatment was performed during the follow-up period in the control group.

Interventions

  • ProcedureNon surgical periodontal therapy

    single session full-mouth scaling and root planing

06

What researchers measure

Primary outcomes

  1. changes in the severity of Erectile Dysfunction

    changes in the severity of Erectile Dysfunction diagnosed by International Index of Erectile Dysfunction between test and control groups. Subjects with scores \> 25 were assessed as men with normal sexual function while those with scores ≤ 25 were diagnosed as patients with erectile dysfunction.severe with a score from 6 to 10, moderate (11-16) and mild (17-25)

    Time frame: 3 months

Secondary outcomes

  1. changes in mean values of TNF-α in serum.Quantitative assessment of TNF-α in serum was done by a commercially available kit (Ray Bio Human TNF-α Enzyme Immunoassay),and was expressed as pg/mL.

    changes between groups throughout the follow-up period in mean values of TNF-α level in serum .

    Time frame: 3 months

  2. changes in mean values of TNF-α in saliva

    changes between groups throughout the follow-up period in mean values of TNF-α level in saliva .Quantitative assessment of TNF-α in saliva and serum was done by a commercially available kit (Ray Bio Human TNF-α Enzyme Immunoassay). and was expressed as pg/mL.

    Time frame: 3 momths

  3. changes in mean values of Clinical attachment level

    changes between groups throughout the follow-up period in mean values of Clinical attachment level (distance from the base of the pocket to cement-enamel junction) which measured in milmiters using a manual probe (Hu-Friedy, Chicago, IL, USA).

    Time frame: 3 months

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 21, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04129814
Lead sponsor
Taibah University
Collaborators
Tanta University
Responsible party
Yasser El Makaky (Associated professor, Taibah University) — Principal investigator
First posted
Oct 17, 2019
Start date
Apr 2016
Primary completion
Jul 2017
Completion
Jul 2017
Last update
Oct 21, 2019

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion